BiotechTube
Home/MiMedx Group/Edward J. Borkowski
EJ

Edward J. Borkowski

Chief Financial Officer

MiMedx Group

Therapeutic Areas

Advanced Wound CareSurgical Recovery

MiMedx Group Pipeline

DrugIndicationPhase
EPIFIX® / AMNIOFIX®Diabetic Foot UlcersPost-Market Study
EPICORD®Surgical Recovery (e.g., Tendon Repair)Clinical Studies
AMNIOBURN®Partial-Thickness BurnsClinical Evaluation
CELERA™Surgical Recovery (Dural Repair)Clinical Studies
HELIOGEN®Ocular Surface DiseaseCommercial
AXIOFILL®Surgical Void FillingCommercial
MiMedx Patient RegistryMultiple Wound & Surgical IndicationsReal-World Evidence

Leadership Team at MiMedx Group

JW
Joseph W. Capper
Chief Executive Officer
DW
Dr. William F. Ennis
Chief Medical Officer
TR
Timothy R. Wright
CEO, Regenerative Medicine & Biologics
RB
Robert B. Stein
President, Biologics
View full MiMedx Group profile